Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 6
2006 11
2007 10
2008 7
2009 5
2010 6
2011 11
2012 7
2013 4
2014 1
2015 4
2016 8
2017 9
2018 7
2019 8
2020 6
2021 4
2022 11
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Human spinal ejaculation generator.
Chéhensse C, Facchinetti P, Bahrami S, Andrey P, Soler JM, Chrétien F, Bernabé J, Clément P, Denys P, Giuliano F. Chéhensse C, et al. Among authors: denys p. Ann Neurol. 2017 Jan;81(1):35-45. doi: 10.1002/ana.24819. Epub 2016 Dec 5. Ann Neurol. 2017. PMID: 27917533
Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2).
Kennelly M, Cruz F, Herschorn S, Abrams P, Onem K, Solomonov VK, Del Rosario Figueroa Coz E, Manu-Marin A, Giannantoni A, Thompson C, Vilain C, Volteau M, Denys P; Dysport CONTENT Program Group. Kennelly M, et al. Among authors: denys p. Eur Urol. 2022 Aug;82(2):223-232. doi: 10.1016/j.eururo.2022.03.010. Epub 2022 Apr 7. Eur Urol. 2022. PMID: 35400537 Free article. Clinical Trial.
Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation-A study from the neuro-urology committee of the French Association of Urology.
Delaval S, Dequirez PL, Hentzen C, Baron M, Mille E, Tariel F, Peyronnet B, Perrouin-Verbe MA, Pierache A, Chartier-Kastler E, Capon G, Cornu JN, Castel-Lacanal E, Gamé X, Karsenty G, Ruffion A, Denys P, Even A, Joussain C, Amarenco G, Phé V, Biardeau X. Delaval S, et al. Among authors: denys p. Mult Scler. 2023 Jul;29(8):1024-1032. doi: 10.1177/13524585231174580. Epub 2023 Jun 2. Mult Scler. 2023. PMID: 37264947
Botulinum neurotoxin A for male lower urinary tract symptoms.
Chartier-Kastler E, Mehnert U, Denys P, Giuliano F. Chartier-Kastler E, et al. Among authors: denys p. Curr Opin Urol. 2011 Jan;21(1):13-21. doi: 10.1097/MOU.0b013e3283410117. Curr Opin Urol. 2011. PMID: 21099691 Free article. Review.
110 results